Rigrodsky & Long, P.A. Investigates Clarient, Inc. Buyout
22 Octubre 2010 - 11:13AM
Business Wire
Rigrodsky & Long, P.A. announces that it is investigating
potential claims against the board of directors of Clarient, Inc.
(“Clarient” or the “Company”) (Nasdaq:CLRT) concerning possible
breaches of fiduciary duty and other violations of law related to
the Company’s entry into an agreement to be acquired by GE
Healthcare (“GE”) in a transaction valued at approximately $580
million. Click here to learn how to join the action:
http://www.rigrodskylong.com/news/ClarientInc-CLRT.
Under the proposed agreement, a subsidiary of GE will commence a
cash tender offer for all outstanding common and preferred shares
of Clarient at $5.00 per common share and $20.00 per preferred
share, in each case payable in cash. GE will then acquire any
Clarient shares not purchased in the tender offer in a second-step
merger at the same price per share paid in the tender offer.
The investigation concerns whether Clarient’s board of directors
failed to adequately shop the Company and obtain the best price
possible for Clarient’s shareholders before entering into the
agreement with GE. Indeed, shareholders holding approximately 47%
of Clarient’s current outstanding voting stock have agreed, among
other things, to tender their shares in the proposed transaction.
Moreover, according to Yahoo! Finance, at least one analyst has set
a price target of $6.00 per share for Clarient stock.
If you own the common stock of Clarient and purchased your
shares before October 22, 2010, if you have information or would
like to learn more about these claims, or if you wish to discuss
these matters or have any questions concerning this announcement or
your rights or interests with respect to these matters, please
contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case
Development Director, of Rigrodsky & Long, P.A., 919 N. Market
Street, Suite 980, Wilmington, Delaware, by telephone at (888)
969-4242, or by e-mail to info@rigrodskylong.com.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly litigates securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, including claims for breach of
fiduciary duty and proxy violations in the Delaware Court of
Chancery and in state and federal courts throughout the United
States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024